	Real-world outcomes of palbociclib plus endocrine therapy in elderly patients with HR+/HER2- advanced breast cancer in Japan: a subgroup analysis of the P-BRIDGE study by age group. Breast Cancer Masuda H, Nagai SE, Hattori M, Yoshinami T, Okamura T, Watanabe K, Nakayama T, Tsuneizumi M, Takabatake D, Harao M, Yoshino H, Mori N, Yasojima H, Oshiro C, Iwase M, Yamaguchi M, Sangai T, Sasada S, Ishida T, Futamura M, Oda H, Muramatsu Y, Masuda N. PMID: 41670927 [PubMed - as supplied by publisher]
	Epithelial-mesenchymal transition and cancer-associated fibroblasts in tumor progression and therapy resistance: mechanistic convergence and therapeutic opportunities. Clin Transl Oncol Singh DK, Gupta R, Kumar U, Gupta S. PMID: 41670820 [PubMed - as supplied by publisher]
	Establishment of insulin resistance-related ten-gene signature in endometrial cancer and identification of ACTL8 as a prognostic and immunological biomarker. Clin Transl Oncol Lu S, Xu J, Sun X, Yuan J, Cheng J, Qin J. PMID: 41670819 [PubMed - as supplied by publisher]
	Genomic alterations and their correlation with metabolic-related genes in lung cancer. Clin Transl Oncol Gaur G, Jha NK, Gambhir L, Acharya SV, Kumar D. PMID: 41670818 [PubMed - as supplied by publisher]
	Inherited cancer syndromes in adult oncology: a referral guide based on malignant tumor and polyp features. Clin Transl Oncol Guilmot A, Belpaire M, Olinger E, De Leener A, Punie K, Duhoux FP. PMID: 41670817 [PubMed - as supplied by publisher]
	Influence of subgroup, location, and tumor volume in medulloblastoma surgery and consideration for second look surgery: a single institution experience. Childs Nerv Syst Power EA, Pumford AD, Futso-Kamga L, Silvera VM, Rechberger JS, Wang L, Schwartz JD, Daniels DJ. PMID: 41670812 [PubMed - indexed for MEDLINE]
	Saying good-bye or final conversations between terminally ill inpatients and family members in the last weeks of life: a nationwide survey of bereaved families. Support Care Cancer Otani H, Morita T, Aoyama M, Tsuneto S, Mori M, Miyashita M. PMID: 41670798 [PubMed - indexed for MEDLINE]
	Perioperative Chemoimmunotherapy vs. Chemotherapy Alone for Gastroesophageal Cancer: A Systematic Review and Meta-Analysis. J Gastrointest Cancer Rodrigues LLC, de Souza RF, Freitas BG, Gomes L, Costa Filho VO, Noronha MM, Visani FLV, Al-Alam O. PMID: 41670791 [PubMed - in process]
	Barrier resolution via patient navigation in the context of cancer care. Support Care Cancer Hoeve ESV, Wightman P, Calhoun E, Hernandez M, Armin JS, Hamann HA. PMID: 41670790 [PubMed - indexed for MEDLINE]
	A composite immune-nutritional and tumor marker score predicts outcomes in LA-ESCC treated with neoadjuvant chemoimmunotherapy and surgery. Discov Oncol Fan Y, Zhou J, Liu X, Ren Q, Lu S, Jin W. PMID: 41670757 [PubMed - as supplied by publisher]
	Defining prognostic subgroups and treatment outcomes in estrogen receptor low-positive de novo metastatic breast cancer. Breast Cancer Res Treat Klugman MF, Aboumrad M, Chen R, Marshall CH, Canzoniero JV, Wolff AC, Visvanathan K. PMID: 41670749 [PubMed - indexed for MEDLINE]
	EMVI as an independent predictor of recurrence and the role of chemotherapy in N0 colonic adenocarcinoma: retrospective Cox regression analysis (2015-2022). Int J Colorectal Dis Bhanderi S, Delaney M, Khan H, O'Neill R, Patel A. PMID: 41670736 [PubMed - indexed for MEDLINE]
	Mechanisms of simplified sitting Badunjin effects on symptom burden: a network-based cross-lagged analysis in advanced cancer patients. Support Care Cancer Zheng J, Zou H, Lu Y, Chen L, Zheng M, Zhu Z, Cheng W, Xiao H. PMID: 41670735 [PubMed - indexed for MEDLINE]
	Bystander effects in photodynamic therapy-treated tumors involve spatiotemporally extended ferroptosis. J Mol Med (Berl) Korbelik M, Girotti AW, Kessel D. PMID: 41670729 [PubMed - indexed for MEDLINE]
	Breaking resistance barriers: ensartinib as a milestone in anaplastic lymphoma kinase-driven non-small cell lung cancer therapy. Naunyn Schmiedebergs Arch Pharmacol Gumma L, Gumma B, Yarrabothula LP. PMID: 41670693 [PubMed - as supplied by publisher]
	Contrast-enhanced ultrasound for precise differentiation of hepatitis-related intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Abdom Radiol (NY) Xiaorong L, Nie F, Wang N, Yang R, Zhang Y, Chen G, Zheng R. PMID: 41670674 [PubMed - as supplied by publisher]
	Beyond the membrane: rethinking EGFR signaling in physiology and cancer. Cell Mol Life Sci Jendrisek G, Mesa D, Conte A, Malabarba MG, Sigismund S. PMID: 41670652 [PubMed - as supplied by publisher]
	Assessment of liver fibrosis and tumor burden in hepatocellular carcinoma using [(18)F]AlF-NOTA-FAPI-04 PET/CT: a prospective study. Eur J Nucl Med Mol Imaging Wang C, Xu K, Li W, Xu L, Zhu K, Dou X, Liu Y, Wang Y, Zhang X, Yue J. PMID: 41670631 [PubMed - as supplied by publisher]
	Follow the "DOTs": VÎ´1+ Î³Î´ T cells as effectors of cancer immunotherapy. J Exp Med Silva-Santos B, Mensurado S, Blanco-Domínguez R, Hayday AC. PMID: 41670625 [PubMed - indexed for MEDLINE]
	Imaging Diagnosis of Hepatocellular Carcinoma: The Presence of an Enhancing Capsule May Be Equal to Other Major Criteria, Independent of Lesion Size. AJR Am J Roentgenol Stuhlfaut J. PMID: 41670540 [PubMed - as supplied by publisher]

Articles 1 - 20 / 1908614

Page 1 of 95431



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy